scheplick

Biotech $PRAN getting crushed pre-market on missed trial result

NASDAQ:PRAN   None
0
.

I work at TradingView helping to build charts, tools, and software for everyone interested in financial markets.

Twitter: twitter.com/scheplick
Blog: scheplick.com/
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.